论文部分内容阅读
目的 探讨冠心病心衰患者应用阿托伐他汀联合美托洛尔治疗的临床效果及对患者心脏功能的影响.方法 随机选取2015年12月—2017年12月收治的冠心病心衰患者60 例,依据治疗方法分为两组,即常规治疗组和常规治疗基础上阿托伐他汀联合美托洛尔治疗组(联合治疗组),每组30 例,对两组患者的临床疗效、心脏功能进行统计分析.结果 联合治疗组患者治疗的总有效率93.3%(28/30)显著高于常规治疗组73.3%(22/30)(P＜0.05),LVEF显著高于常规治疗组(P＜0.05),LVESD、LVEDD均显著低于常规治疗组(P＜0.05).结论 冠心病心衰患者应用阿托伐他汀联合美托洛尔治疗的临床效果好,能够有效改善患者心脏功能.“,”Objective To investigate the clinical effect of atorvastatin combined with metoprolol in the treatment of patients with coronary artery disease combined with heart failure and its effect on cardiac function. Methods 60 cases of patients with coronary artery disease combined with heart failure from December 2015 to December 2017 in Suzhou Hospital of Traditional Chinese Medicine were randomly selected, these patients were divided into two groups according to the treatment methods, namely, conventional treatment group and atorvastatin combined with metoprolol treatment based on conventional treatment group (combined treatment group), 30 cases in each group, and the clinical efficacy and cardiac functions of the two groups were statistically analyzed. Results The total treatment effective rate of the combined treatment group 93.3% (28/30) was significantly higher than that of the conventional treatment group 73.3% (22/30) (P＜0.05), the LVEF was significantly higher than that of the conventional treatment group (P＜0.05), the LVESD and LVEDD were significantly lower than those of the conventional treatment group (P＜0.05). Conclusion Atorvastatin combined with metoprolol in the treatment of patients with coronary artery disease combined with heart failure has good clinical effect and can effectively improve cardiac function of patients.